← FDA Drug Approvals (Drugs@FDA)

REGADENOSON

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INDIES PHARMA · Approved 2024-08-22

Drug application

FDA Application #

ANDA218054

Application type

Abbreviated New Drug Application (Generic)

Brand name

REGADENOSON

Generic name

REGADENOSON

Active ingredients

REGADENOSON

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

INDIES PHARMA

Manufacturer

Indies Pharma Jamaica Limited

First approval

2024-08-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown